27.62
前日終値:
$28.42
開ける:
$28.36
24時間の取引高:
287.51K
Relative Volume:
0.38
時価総額:
$1.17B
収益:
$384.10M
当期純損益:
$-9.07M
株価収益率:
-197.29
EPS:
-0.14
ネットキャッシュフロー:
$11.10M
1週間 パフォーマンス:
-1.82%
1か月 パフォーマンス:
-3.03%
6か月 パフォーマンス:
+43.56%
1年 パフォーマンス:
+28.93%
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile
名前
Kiniksa Pharmaceuticals International Plc
セクター
電話
(781) 431-9100
住所
23 OLD BOND STREET, FLOOR 3, LONDON
KNSA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
KNSA
Kiniksa Pharmaceuticals International Plc
|
27.62 | 2.10B | 384.10M | -9.07M | 11.10M | -0.14 |
![]()
ZTS
Zoetis Inc
|
150.56 | 69.30B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 47.50B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
HLN
Haleon Plc Adr
|
9.615 | 44.47B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.30 | 18.83B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
298.56 | 13.43B | 2.99B | 1.21B | 1.13B | 25.06 |
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-03-13 | 開始されました | Citigroup | Buy |
2024-09-13 | 開始されました | Jefferies | Buy |
2024-05-03 | 開始されました | Wells Fargo | Overweight |
2020-06-29 | 繰り返されました | BofA Securities | Buy |
2020-04-01 | 開始されました | BofA/Merrill | Buy |
2019-03-11 | 開始されました | Barclays | Overweight |
2018-12-12 | 繰り返されました | Wedbush | Outperform |
2018-06-19 | 開始されました | JMP Securities | Mkt Outperform |
すべてを表示
Kiniksa Pharmaceuticals International Plc (KNSA) 最新ニュース
Kiniksa Pharmaceuticals International’s (KNSA) “Outperform” Rating Reaffirmed at Wedbush - Defense World
Teacher Retirement System of Texas Decreases Stock Holdings in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World
Insider Selling: Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) COO Sells 18,900 Shares of Stock - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Shares Sold by Rice Hall James & Associates LLC - MarketBeat
Kiniksa Pharmaceuticals COO Eben Tessari Buys, Sells Shares on July 14 - AInvest
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Shares Bought by GAMMA Investing LLC - Defense World
Wealth Enhancement Advisory Services LLC Invests $301,000 in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - Defense World
KNSA: Analyst Maintains Overweight Rating, Raises Price Target | - GuruFocus
Allspring Global Investments Holdings LLC Sells 439,622 Shares of Dr. Reddy’s Laboratories Ltd (NYSE:RDY) - Defense World
Allspring Global Investments Holdings LLC Trims Holdings in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World
Allspring Global Investments Holdings LLC Raises Holdings in Broadstone Net Lease, Inc. (NYSE:BNL) - Defense World
Wealth Enhancement Advisory Services LLC Purchases New Shares in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World
Kiniksa Pharmaceuticals: A 7.9 Score and Room for Growth - AOL.com
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Peregrine Capital Management LLC Purchases 65,147 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat
Asset Management One Co. Ltd. Makes New $41,000 Investment in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World
AMI Asset Management Corp Has $1.73 Million Position in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat
Genentech ends ulcerative colitis study for drug from $700 million dealSan Francisco Business Times - The Business Journals
GAMMA Investing LLC Purchases 26,826 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) COO Eben Tessari Sells 17,300 Shares - MarketBeat
Rhumbline Advisers Acquires 3,745 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World
Kiniksa pharma COO Tessari sells $489k in shares By Investing.com - Investing.com South Africa
Kiniksa Pharmaceuticals: Arcalyst Performs, KPL-387 Advancing Fast (NASDAQ:KNSA) - Seeking Alpha
Lewis & Ellis acquires Huggins Actuarial Services - Yahoo
UK court rules insurers must pay more than $1bn for planes seized in Russia - Yahoo
Payment software firm Payrails raises $32m in funding - Yahoo
WRAP EU leads textiles extended producer responsibility talks - Yahoo
Canary raises $80m to fuel expansion in hospitality AI - Yahoo
FirmaPak expands global footprint with Lighthouse Packaging acquisition - Yahoo
FDA approves label expansion of AbbVie hepatitis C therapy - Yahoo
Israel attacks Iran, stock market futures tumble - Yahoo
Green Bay Packaging Executive Vice President Bryan Hollenbach to retire in August - Yahoo
Jio BlackRock gets nod to operate as investment adviser in India - Yahoo
Output of key food commodities “on course for new records” – FAO - Yahoo
Why Oklo Stock Dropped on Thursday - Yahoo
Medtech leaders unite on Capitol Hill to fight tariffs - Yahoo
Actabl launches new ProfitSword digital night audit feature for hotels - Yahoo
UCC Holding and Ashghal launch 3D Printed Schools Project in Qatar - Yahoo
Grant Thornton Advisors appoints new COO - Yahoo
Biggby Coffee unveils first brand refresh - Yahoo
Prime Drink Group’s bottling unit enters receivership - Yahoo
Del Taco expands to Louisville with new franchise agreement - Yahoo
Trump’s Treasury Sec Admits It’s Another TACO Day With China - Yahoo
Hakkers and Paebbl introduce carbon-storing solution at Port of Rotterdam - Yahoo
Mistral unveils Europe’s first AI reasoning model Magistral - Yahoo
Costco Announces Important Change for Certain Members Starting June 30 - Yahoo
Transcript : Kiniksa Pharmaceuticals International, plc Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - MarketScreener
MSD receives FDA approval for Enflonsia to prevent RSV - Yahoo
Kiniksa Pharmaceuticals Executives Sell Shares - TradingView
KNSA stock soars to 52-week high, hits $29.71 amid robust gains - Investing.com UK
Kiniksa Pharmaceuticals International Plc (KNSA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):